Jamieson Wellness Capitalizes on Surging Chinese Demand
02.03.2026 - 01:32:52 | boerse-global.deJamieson Wellness Inc. has reported robust growth for its 2025 fiscal year, driven predominantly by exceptional performance in its Far East operations. Despite facing near-term margin pressure from increased expenditures, the company's financial position remains solid, underpinned by remarkable consumer demand in China. The central question now is whether this momentum can be leveraged to offset rising costs in the coming year.
Financial Performance and Shareholder Returns
For shareholders, the past year was marked by significant capital returns. Jamieson allocated C$37.9 million toward share repurchases and distributed approximately C$37.2 million in dividends. The company’s liquidity position, including cash and credit facilities, stood at C$126.6 million at year-end.
Reflecting this commitment, the Board of Directors confirmed a quarterly cash dividend of C$0.23 per common share last Thursday. This distribution, totaling roughly C$9.5 million, will be payable on March 16, 2026, to shareholders of record as of March 6, 2026.
China Market Drives Record Growth
The standout contributor to annual performance was the Chinese market, where sales skyrocketed by 56% year-over-year. This surge was instrumental in delivering consolidated annual revenue growth of approximately 12%. In the fourth quarter alone, Jamieson generated revenue of C$277.66 million, with earnings per share of C$0.90. The quarter's return on equity was 8.99%, supported by a net margin of 5.57%.
Should investors sell immediately? Or is it worth buying Jamieson Wellness?
These gains were partially offset in Q4 by a 20% rise in selling, general, and administrative expenses. Company leadership attributed this increase to heightened marketing investments and costs associated with recent acquisitions. Furthermore, revenue from strategic partnerships saw a modest decline of 4.4%.
Guidance Points to Continued Expansion
Looking ahead to the 2026 fiscal year, management has provided an optimistic outlook. The company forecasts revenue to climb to a range of C$895 million to C$935 million, representing projected growth of 9% to 14%. Adjusted EBITDA is anticipated to be between C$174 million and C$181 million. On a per-share basis, Jamieson expects adjusted diluted earnings per share to land between C$2.08 and C$2.21.
Ad
Jamieson Wellness Stock: New Analysis - 2 March
Fresh Jamieson Wellness information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
So schätzen die Börsenprofis Jamieson Aktien ein!
Für. Immer. Kostenlos.

